Ainos logo
Ainos
AIMD | NASDAQ
Chart Builder DCF Calculator
$1.14
-$0.09 (-7.32%)
At close: Nov 16, 2026, 4:00 PM ET
$1.06
-$0.08 (-7.02%)
After-hours: Nov 16, 2026, 7:57 PM ET

Ainos Company Profile

Company profile explained

Company Profile

Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.

Key Executives

Name Position
Chun-Hsien Tsai Chief Executive Officer, President & Chairman of the Board
Hsin-Liang Lee Chief Financial Officer
Chih-Heng Lu Director of Corporate Developoment

Latest SEC Filings

Date Type Title
Oct 16, 2026 8-K Current Report
Sep 28, 2026 8-K Current Report
Aug 03, 2026 8-K Current Report
Aug 03, 2026 10-Q Quarterly Report
Jul 24, 2026 424B5 Filing
Jul 10, 2026 8-K Current Report
Jul 09, 2026 8-K Current Report
Jun 09, 2026 4 Filing
Jun 05, 2026 4 Filing
Jun 01, 2026 4 Filing
View All SEC Filings ➞
Ainos
Ainos logo
Country United States
IPO Date Jan 8, 2021
Industry Biotechnology
Sector Healthcare
Employees 41
CEO Chun-Hsien Tsai

Contact Details

3050 Post Oak Boulevard Houston, Texas 77056 United States

Stock Details

Ticker Symbol AIMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001014763
CUSIP Number 00902F402
ISIN Number US00902F4028
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.